What Happened With the iPhone 12

In September 2023, France’s National Frequencies Agency (ANFR) announced that the iPhone 12 exceeded the European Union’s specific absorption rate (SAR) limit for electromagnetic radiation absorption when held in the hand or kept in a pocket. The French regulator ordered Apple to halt iPhone 12 sales in France and mandated a software update to bring the device into compliance. Apple issued the update; the ban was lifted after remediation.

This was not a minor regulatory footnote. It was the first time a major market had pulled an Apple flagship device from sale over SAR compliance, and it reopened a broader conversation about how SAR testing protocols relate to real-world exposure and whether current regulatory frameworks adequately address modern usage patterns.

The SAR Limit Problem

SAR — specific absorption rate — measures the rate at which the body absorbs RF energy from a wireless device, expressed in watts per kilogram of body tissue. The EU limit is 2.0 W/kg averaged over 10 grams of tissue; the US FCC limit is 1.6 W/kg over 1 gram. Both limits were established in the 1990s based on thermal effects models (tissue heating) and testing protocols that may not reflect how devices are actually used.

The iPhone 12 France case specifically involved the “limb SAR” measurement — the test for when the device is held in the hand or kept in a trouser pocket — rather than the head SAR used for calls. The device passed head SAR testing but failed limb SAR. This distinction matters: it suggests that how and where you carry a device, not just whether you hold it to your ear, is relevant to compliance and exposure.

What This Means for Current Regulatory Frameworks

The IARC/WHO Group 2B classification (2011) categorized radiofrequency electromagnetic fields as “possibly carcinogenic to humans.” PACE Resolution 1815 (2011) called for more stringent precautionary measures. The France iPhone 12 case is evidence that even within existing regulatory frameworks, real-world device usage can exceed the limits those frameworks set — which raises the question of whether compliance under laboratory testing conditions translates to compliance under actual usage conditions.

This regulatory gap is precisely the context in which Aires’ coherence modulation approach is relevant. Rather than operating on field intensity (which is what SAR measures and regulators limit), Aires technology addresses field coherence properties — the structural characteristic of the electromagnetic field that the current regulatory framework doesn’t measure or limit, but that the biological research increasingly identifies as the relevant variable.

The Precautionary Principle in Practice

The France ban was an application of the precautionary principle at the regulatory level: when a device exceeds established limits, the response is immediate action, not waiting for longitudinal health data. For individuals, the same logic applies. The Dyuzhikova et al. (2019) cytogenetics research — showing chromosomal aberration frequency reduction from 9.8% to 2.7% (p<0.001) with Aires device use — provides measurable biological evidence that precautionary action at the individual level produces measurable outcomes.